Evidence map›Paper›PMID 29749530›Full record

ArticleOncology reports2018

Long non-coding RNA SNHG1 predicts a poor prognosis and promotes colon cancer tumorigenesis.

Huan Yang, Shuang Wang, Yu-Jun Kang, Chuan Wang, Yongzhu Xu, Yi Zhang, Zheng Jiang

Open access · hybridAbstract read
In one paragraph

Article in Oncology reports, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 24 papers.

0numbers the graph read from it
0cells of the map it votes in
24citing papers in PubMed
1.8field-weighted citation impact, top 16% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

24 citing papers in PubMed, 41 citations in OpenAlex.

  1. Review
  2. Article
  3. Review
  4. Review
  5. Article
  6. Article
  7. Article
  8. Article
  9. An Overview of Long Non-Coding (lnc)RNAs in Neuroblastoma.International journal of molecular sciences · 2021
    Review
  10. Article
  11. Review
  12. Article
  13. Review
  14. Article
  15. Overexpression of LncRNAOncoTargets and therapy · 2020
    Article
  16. Article
  17. Article
  18. Review
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 3 institutions in 1 country.

Huan YangDepartment of Gastroenterology, The First Affiliated Hospital, Chongqing Medical University, Chongqing 400016, P.R. China.
Shuang WangDepartment of Gastroenterology, Chongqing People's Hospital, Chongqing 400016, P.R. China.
Yu-Jun KangDepartment of Gastroenterology, Chongqing People's Hospital, Chongqing 400016, P.R. China.
Chuan WangDepartment of Gastroenterology, Chongqing People's Hospital, Chongqing 400016, P.R. China.
Yongzhu XuChongqing Health Service Center, Chongqing 400000, P.R. China.
Yi ZhangKey Laboratory of Birth Defects and Reproductive Health, Chongqing Population and Family Planning of Chongqing Science and Technology Research Institute, Chongqing 400000, P.R. China.
Zheng JiangDepartment of Gastroenterology, The First Affiliated Hospital, Chongqing Medical University, Chongqing 400016, P.R. China.
First People's Hospital of Chongqing · CNFirst Affiliated Hospital of Chongqing Medical University · CNChongqing Population and Family Planning Science and Technology Research Institute · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Colon cancer is the main cause of cancer mortality worldwide. Its poor prognosis is mainly ascribed to high recurrence rates. Identifying novel prognostic biomarkers and therapeutic key points for management is crucial and important. Long non-coding RNAs (lncRNAs) are a class of RNAs, which have various roles in carcinogenicity and molecular mechanisms. The lncRNA small nucleolar RNA host gene 1 (SNHG1) contributes to the promotion of tumor development, however, the connections between SNHG1 and colon cancer are still unclear. The aim of the present study was to investigate the clinical significance, the biological functions, and the potential mechanism of SNHG1 in colon cancer. In the present study, we referred to the Oncomine database and used RT-qPCR to determine that SNHG1 expression was significantly higher both in colon cancer tissues and cancerous cell lines than in normal samples. Cell functional experiments were performed after knockdown of SNHG1, including Cell Counting Kit-8 assay, colony formation assay, Transwell® assay, and flow cytometric analyses of cell apoptosis, which suggested that SNHG1 stimulated colon cancer cell proliferation, promoted cell invasion and migration, and inhibited apoptosis. Immunohistochemical staining and western blotting experiments revealed that in colon cancer cells with SNHG1 knockdown, β-catenin, c-Myc and cyclin D1 protein levels were decreased, while E-cadherin was increased, which suggested that SNHG1 promoted colon cancer cell proliferation, migration and invasion through the Wnt/β-catenin signaling pathway. Our results indicated that SNHG1 and its interrelated components may be future therapeutic targets of carcinoma of the colon.

Indexed as

PrognosisApoptosisbeta CateninCadherinsCarcinogenesisCell MovementCell ProliferationColonic NeoplasmsCyclin D1FemaleGene Expression Regulation, NeoplasticHumansMaleMiddle AgedProto-Oncogene Proteins c-mycRNA, Long Noncodingbeta CateninCadherinsCTNNB1 protein, humanCyclin D1long non-coding RNA SNHG1, humanMYC protein, humanProto-Oncogene Proteins c-mycRNA, Long Noncoding

Identifiers

PMID29749530
PMCPMC6059747
OpenAlexW2800854993

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.